Literature DB >> 20139750

Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART.

Fengyi Jin1, James Jansson, Matthew Law, Garrett P Prestage, Iryna Zablotska, John C G Imrie, Susan C Kippax, John M Kaldor, Andrew E Grulich, David P Wilson.   

Abstract

OBJECTIVE: The objective of this study is to estimate per-contact probability of HIV transmission in homosexual men due to unprotected anal intercourse (UAI) in the era of HAART.
DESIGN: Data were collected from a longitudinal cohort study of community-based HIV-negative homosexual men in Sydney, Australia.
METHODS: A total of 1427 participants were recruited from June 2001 to December 2004. They were followed up with 6-monthly detailed behavioral interviews and annual testing for HIV till June 2007. Data were used in a bootstrapping method, coupled with a statistical analysis that optimized a likelihood function for estimating the per-exposure risks of HIV transmission due to various forms of UAI.
RESULTS: During the study, 53 HIV seroconversion cases were identified. The estimated per-contact probability of HIV transmission for receptive UAI was 1.43% [95% confidence interval (CI) 0.48-2.85] if ejaculation occurred inside the rectum, and it was 0.65% (95% CI 0.15-1.53) if withdrawal prior to ejaculation was involved. The estimated transmission rate for insertive UAI in participants who were circumcised was 0.11% (95% CI 0.02-0.24), and it was 0.62% (95% CI 0.07-1.68) in uncircumcised men. Thus, receptive UAI with ejaculation was found to be approximately twice as risky as receptive UAI with withdrawal or insertive UAI for uncircumcised men and over 10 times as risky as insertive UAI for circumcised men.
CONCLUSION: Despite the fact that a high proportion of HIV-infected men are on antiretroviral treatment and have undetectable viral load, the per-contact probability of HIV transmission due to UAI is similar to estimates reported from developed country settings in the pre-HAART era.

Entities:  

Mesh:

Year:  2010        PMID: 20139750      PMCID: PMC2852627          DOI: 10.1097/QAD.0b013e3283372d90

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  31 in total

1.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

Authors:  R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy.

Authors:  David P Wilson
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

3.  Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: the health in men study.

Authors:  Fengyi Jin; Garrett P Prestage; Limin Mao; Susan C Kippax; Catherine M Pell; Basil Donovan; David J Templeton; Janette Taylor; Adrian Mindel; John M Kaldor; Andrew E Grulich
Journal:  J Infect Dis       Date:  2006-07-28       Impact factor: 5.226

Review 4.  Enhanced efficiency of female-to-male HIV transmission in core groups in developing countries: the need to target men.

Authors:  N O'Farrell
Journal:  Sex Transm Dis       Date:  2001-02       Impact factor: 2.830

5.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

Review 6.  Primary HIV infection.

Authors:  Ade Apoola; Sammena Ahmad; Keith Radcliffe
Journal:  Int J STD AIDS       Date:  2002-02       Impact factor: 1.359

7.  HIV-1 transmission, by stage of infection.

Authors:  T Déirdre Hollingsworth; Roy M Anderson; Christophe Fraser
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

Review 8.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.

Authors:  Suzanna Attia; Matthias Egger; Monika Müller; Marcel Zwahlen; Nicola Low
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

9.  Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men.

Authors:  Fengyi Jin; June Crawford; Garrett P Prestage; Iryna Zablotska; John Imrie; Susan C Kippax; John M Kaldor; Andrew E Grulich
Journal:  AIDS       Date:  2009-01-14       Impact factor: 4.177

10.  Circumcision and risk of HIV infection in Australian homosexual men.

Authors:  David J Templeton; Fengyi Jin; Limin Mao; Garrett P Prestage; Basil Donovan; John Imrie; Susan Kippax; John M Kaldor; Andrew E Grulich
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

View more
  110 in total

1.  Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.

Authors:  Frederik Graw; Thomas Leitner; Ruy M Ribeiro
Journal:  Epidemics       Date:  2012-05-02       Impact factor: 4.396

2.  It is too early to discuss HIV elimination.

Authors:  David P Wilson; Sean R Hosein
Journal:  Public Health Rep       Date:  2010 Nov-Dec       Impact factor: 2.792

3.  Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.

Authors:  G Matusali; N Dereuddre-Bosquet; A Le Tortorec; M Moreau; A-P Satie; D Mahé; P Roumaud; O Bourry; N Sylla; S Bernard-Stoecklin; A Pruvost; R Le Grand; N Dejucq-Rainsford
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

4.  Latent class profiles of internalizing and externalizing psychosocial health indicators are differentially associated with sexual transmission risk: Findings from the CFAR network of integrated clinical systems (CNICS) cohort study of HIV-infected men engaged in primary care in the United States.

Authors:  Matthew J Mimiaga; Katie Biello; Sari L Reisner; Heidi M Crane; Johannes Wilson; Chris Grasso; Mari M Kitahata; Wm Christopher Mathews; Kenneth H Mayer; Steven A Safren
Journal:  Health Psychol       Date:  2015-02-02       Impact factor: 4.267

5.  Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV prevention.

Authors:  Heather A Pines; Pamina M Gorbach; Cathy J Reback; Raphael J Landovitz; Matt G Mutchler; Ronald Mitsuyasu
Journal:  AIDS Care       Date:  2014-07-15

6.  High Prevalence of Concurrent Male-Male Partnerships in the Context of Low Human Immunodeficiency Virus Testing Among Men Who Have Sex With Men in Bamako, Mali.

Authors:  Avi Hakim; Padmaja Patnaik; Nouhoum Telly; Tako Ballo; Bouyagui Traore; Seydou Doumbia; Maria Lahuerta
Journal:  Sex Transm Dis       Date:  2017-09       Impact factor: 2.830

7.  The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study.

Authors:  Julia Ebert; Jan Peter Sperhake; Olaf Degen; Ann Sophie Schröder
Journal:  Forensic Sci Med Pathol       Date:  2018-05-18       Impact factor: 2.007

8.  Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions.

Authors:  Martin Hoenigl; Antoine Chaillon; Sanjay R Mehta; Davey M Smith; Joshua Graff-Zivin; Susan J Little
Journal:  J Infect       Date:  2016-08-11       Impact factor: 6.072

9.  HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies.

Authors:  Arielle Lasry; Stephanie L Sansom; Richard J Wolitski; Timothy A Green; Craig B Borkowf; Pragna Patel; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

Review 10.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.